Adma Biologics Incの売上総利益

Adma Biologics Incの売上総利益 は何ですか。

Adma Biologics Incの売上総利益 は34.44%です。

売上総利益 の定義は何ですか。



売上総利益は、売上と商品の売上原価との差を収益で除してパーセンテージで表したものです。

Gross margin is a type of profit margin, specifically a form of profit divided by net revenue. It is generally calculated as the selling price of an item, minus the cost of goods sold (production or acquisition costs, not including indirect fixed costs like rent, or administrative costs). The purpose of margins is to give a description of the gross profit.

NASDAQのセクタHealth Careにおける売上総利益 の企業と比べるAdma Biologics Inc

Adma Biologics Incは何をしますか。

adma is a late-stage biopharmaceutical company that develops, manufactures and intends to commercialize specialty plasma-based biologics for the treatment and prevention of primary immune deficiency disease (pidd) and certain infectious diseases. adma's mission is to develop and commercialize plasma-derived, human immune globulins targeted to niche patient populations for the treatment and prevention of certain infectious diseases. the target patient populations include immune-compromised individuals who suffer from an underlying immune deficiency disease, or who may be immune-compromised for medical reasons. adma’s lead product candidate, ri-002, has completed a phase iii clinical trial in patients with pidd and has met the primary endpoint. a bla for ri-002 was accepted by the fda on september 18, 2015. the company has received u.s. patent 9,107,906. for more information, please visit the company's website at www.admabiologics.com.

Adma Biologics Incと類似の売上総利益